Assessment of anti SARS-CoV-2 antibodies present in convalescent plasma donors aimed at being used in COVID-19 treatment

Journal Title: One Health & Risk Management - Year 2021, Vol 2, Issue 2

Abstract

Introduction. Currently, COVID-19 treatment includes several options, including the use of convalescent plasma. Therefore, the presence of anti-SARS-CoV-2 in blood donors after the clinical recovery of COVID-19, depending on their place of residence, age and the clinical manifestation of the disease is of scientific-practical interest. Material and methods. A total of 119 donors among patients were examined, namely males aged 18-60 years, having a past history of COVID-19 disease, being confirmed by PCR and treated, showing a negative PCR-based test result, which was performed at least 14 days after clinical recovery. The presence/absence of anti-SARS-CoV-2 was assessed by enzyme-linked immunosorbent assay. Results. The obtained data showed that 87.4% of plasma donors responded to COVID-19 infection by anti-SARS-CoV-2 IgG expression, which is predominantly found in the 26-35 age group. Most donors experienced mild and medium clinical forms. It is important to note that all severe clinical manifestations of the infection were followed by the formation of anti-SARS-CoV-2 IgG. Urban living environment was predominantly found in convalescent donors (75.0%), which indicates that they are better informed by medical institutions. Conclusions. The study shows that male blood donors aged 18-60 years, subsequently cured and being positive for anti-SARS-CoV-2 IgG can serve as a source of fresh plasma used for the treatment of COVID-19 patients.

Authors and Affiliations

Constantin SPÎNU, Svetlana CEBOTARI, Octavian SAJIN, Igor SPÎNU, Ala DONOS, Ana VOLNEANSCHI, Igor GOSTEV, Iurie DOPIRA

Keywords

Related Articles

Mental health during the COVID-19 quarantine in five countries

Introduction. As part of the holistic concept of health, mental health can be focused on prevention of contagion and coping with the disease and its consequences in the context of the current COVID-19 pandemic. The prese...

Dietary improvement of the iron statute of the rats with experimental anemia

Introduction. One of the major problems characterizing the nutritional status is the iron deficiency, which leads to decreased immunity, increased incidence of infectious diseases and anemia. Obviously, only well-thought...

Cardiovascular damage in seronegative spondylarthriti

Introduction. Cardiovascular mortality in patients diagnosed with seronegative spondyloarthritis (SSN) is on the rise. Impairment of the cardiovascular system in ankylosing spondylitis (SpA) is 20-40%, in psoriatic arthr...

Peculiarities of extraction of β-lactoglobuline in protein mineral concentrates at electroactivation of whey

Introduction. Whey is a by-product and an excellent source of proteins that is rather aggressive due to a large amount of organic substances it contains. The electro-activation of whey applied in the experiments is a was...

Mesenteric panniculitis: therapeutic aspects in the light of a clinical case

Introduction: Mesenteric panniculitis is a rare medical condition. Its incidence is between 0.16% - 3.4%. The small number of cases of PMN and the ignorance of its causes, pathogenesis and treatment significantly affect...

Download PDF file
  • EP ID EP693652
  • DOI 10.38045/ohrm.2021.2.08
  • Views 170
  • Downloads 0

How To Cite

Constantin SPÎNU, Svetlana CEBOTARI, Octavian SAJIN, Igor SPÎNU, Ala DONOS, Ana VOLNEANSCHI, Igor GOSTEV, Iurie DOPIRA (2021). Assessment of anti SARS-CoV-2 antibodies present in convalescent plasma donors aimed at being used in COVID-19 treatment. One Health & Risk Management, 2(2), -. https://europub.co.uk./articles/-A-693652